Conjugate vaccines against Pseudomonas aeruginosa and malaria
- PMID: 2510972
Conjugate vaccines against Pseudomonas aeruginosa and malaria
Similar articles
-
Immunologic considerations for the development of conjugate vaccines.Contrib Microbiol Immunol. 1989;10:11-7. Contrib Microbiol Immunol. 1989. PMID: 2510971 Review. No abstract available.
-
Contemporary trends in conjugate vaccine development.Contrib Microbiol Immunol. 1989;10:1-10. Contrib Microbiol Immunol. 1989. PMID: 2510970 Review. No abstract available.
-
Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine.Zentralbl Bakteriol A. 1980 Mar;246(3):353-62. Zentralbl Bakteriol A. 1980. PMID: 6775443
-
Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type.J Hyg Epidemiol Microbiol Immunol. 1987;31(3):343-52. J Hyg Epidemiol Microbiol Immunol. 1987. PMID: 3119704
-
Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).J Hyg Epidemiol Microbiol Immunol. 1982;26(4):417-27. J Hyg Epidemiol Microbiol Immunol. 1982. PMID: 6819316
Cited by
-
Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.Infect Immun. 1994 Apr;62(4):1137-43. doi: 10.1128/iai.62.4.1137-1143.1994. Infect Immun. 1994. PMID: 8132318 Free PMC article.
-
Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.Infect Immun. 1994 Sep;62(9):3608-16. doi: 10.1128/iai.62.9.3608-3616.1994. Infect Immun. 1994. PMID: 7520416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical